Prescribing practices for intravenous aminoglycosides in UK Cystic Fibrosis clinics: A questionnaire survey

Journal of Cystic Fibrosis

Volumn 13, Issue 4, 2014, Pages 424-427

  Smyth, Alan R ^a   Campbell, Emma L ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Aminoglycosides; Cystic fibrosis; Nephrotoxicity; Obstacles to evidence based practice; Once daily dosing

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; GENTAMICIN; TOBRAMYCIN; AMINOGLYCOSIDE;

ANTIBIOTIC THERAPY; ARTICLE; CYSTIC FIBROSIS; EVIDENCE BASED PRACTICE; FOLLOW UP; HEALTH SURVEY; HUMAN; MULTICENTER STUDY; PRACTICE GUIDELINE; PRESCRIPTION; PSEUDOMONAS AERUGINOSA; QUESTIONNAIRE; UNITED KINGDOM; ADOLESCENT; ADULT; CHILD; CLINICAL TRIAL; COMPLICATION; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; INCIDENCE; MALE; PROCEDURES; RESPIRATORY TRACT INFECTIONS; YOUNG ADULT;

ADOLESCENT; ADULT; AMINOGLYCOSIDES; CHILD; CYSTIC FIBROSIS; DRUG ADMINISTRATION SCHEDULE; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; POPULATION SURVEILLANCE; QUESTIONNAIRES; RESPIRATORY TRACT INFECTIONS; YOUNG ADULT;

EID: 84902328784     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2013.11.007     Document Type: Article

References (10)

1. U.K.Cystic Fibrosis Trust UK CF Registry. Annual Data Report 2011 2013, Cystic Fibrosis Trust, Bromley.
2. Antibiotic treatment for cystic fibrosis. Report of the UK cystic fibrosis trust antibiotic group 2009, UK Cystic Fibrosis Trust, London.
3. Smyth A., Lewis S., Bertenshaw C., Choonara I., McGaw J., Watson A. Case-control study of acute renal failure in patients with cystic fibrosis in the UK. Thorax 2008, 63:532-535.
4. Smyth A.R., Bhatt J. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis. Cochrane Database Syst Rev 2012, (2). (Art. No.: CD002009. pub4). 10.1002/14651858.CD002009.
5. Flume P.A., Mogayzel P.J., Robinson K.A., Goss C.H., Rosenblatt R.L., Kuhn R.J., et al. Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med 2009, 180:802-808.
6. Tan K.H.V., Hyman-Taylor P., Mulheran M., Knox A., Smyth A. To the editor: lack of concordance in the use and monitoring of intravenous aminoglycosides in UK cystic fibrosis centers. Pediatr Pulmonol 2002, 33:165.
7. Smyth A., Tan K.H.V., Hyman-Taylor P., Mulheran M., Lewis S., Stableforth D., et al. Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis-the TOPIC study: a randomised controlled trial. Lancet 2005, 365:573-578.
8. Barza M., Ioannidis J.P.A., Cappelleri J.C., Lau J. Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ 1996, 312:338-345.
9. Phillips J.A., Bell S.C. Aminoglycosides in cystic fibrosis: a descriptive study of current practice in Australia. Intern Med J 2001, 31:23-26.
10. Soulsby N., Bell S., Greville H., Doecke C. Intravenous aminoglycoside usage and monitoring of patients with cystic fibrosis in Australia. What's new?. Intern Med J 2009, 39:527-531.